Foghorn Therapeutics Inc.

NASDAQ: FHTX · Real-Time Price · USD
5.08
-0.06 (-1.26%)
At close: Aug 15, 2025, 2:03 PM

Foghorn Therapeutics Revenue

Foghorn Therapeutics reported an annual revenue of $22.6M, reflecting a -33.83% growth. For the quarter ending June 30, 2025, Foghorn Therapeutics generated $7.56M in revenue.
Revenue (ttm)
22.6M
Revenue Growth
-33.83%
Price / Sales Ratio
11.46
Revenue / Employee
201.8K
Employees
112
Market Cap
287.17M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.